HK inno.N – Startup Investor Profile

General Info

Develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products.
Location: Seoul
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a

corporate-vc

Want to start building warm intros with this investor?

Get Started for Free

🤖 AI Activity Report

Status: not-found

AI Reasoning: Searches of HK inno.N public materials and news (company IR site, Korean media) did not reveal any clear record of HK inno.N making venture investments in startups. Available items relate to corporate earnings, drug development and trials (e.g., Cellbion, ecnoglutide), not investments in external startups. No dated startup investment was found to calculate recency; therefore defaulting to not-found.

Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.



Access all contact details of HK inno.N

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.

Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.

Trusted by Founders like You

Find your matching investors using AI

Sign up to EasyVC